BDBM516549 (2S)-1-[(2R)-2phenyl-2- (piperidin-1-yl)acetyl]-N-(4-{5- [({(2S)-1-[(2R)-2-phenyl-2- (piperidin-1-yl)acetyl]pyrrolidin- 2-yl}carbonyl)amino]-1H-indol- 2-yl}phenyl)pyrrolidine-2- carboxamide::US11053243, Example 60

SMILES O=C(Nc1ccc(-c2cc3cc(NC(=O)[C@@H]4CCCN4C(=O)[C@@H](c4ccccc4)N4CCCCC4)ccc3[nH]2)cc1)[C@@H]1CCCN1C(=O)[C@@H](c1ccccc1)N1CCCCC1

InChI Key InChIKey=ALOOORKLRZMRJL-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 516549   

TargetGenome polyprotein(HCV)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 516549BDBM516549(US11053243, Example 60 | (2S)-1-[(2R)-2phenyl-2- (...)
Affinity DataEC50:  0.130nMAssay Description:Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent